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The relationship between smoking habits and the risk of benign breast disease (8BD) was analyzed using data from a
case-control study conducted between 1981 and 1983 in the greater Milan area. Northern Italy. Cases (n - 288) were
women with histologically confirmed BBD (203 dysplasia, 85 benign tumours) referred to the National Cancer Institute
of Milan for biopsies. Controls were women (n - 291) seen on selected days for a cytological smear for cervical cancer
in outpatient clinics of the same Institute. No consistent association emerged between various indicators of smoking
habits (smoking status, number of cigarettes smoked per day, duration of smoking) and the risk of BBD. Compared
with never smokers the relative risk (RR) of all BBD combined was 0.7 (95% confidence interval, Cl: 0.4-1.3) in
exsmokers, 1.4(95% Cl: 0.8-2.5) in smokers of less than 10 cigarettes per day, and 1.1 (95% Cl: 0.7-1.7) in smokers of
10 or more cigarettes per day. There was some suggestion that the risk may be below unity post-menopause, but the
relative risks for smokers were not statistically different in pre- (RR = 1.2; 95% Cl: 0.8-1.8) and post-menopausal
(RR -0.6; 95% Cl: 0.2-1.7) women. The risk of benign tumours (chiefly fibradenoma) was higher in current smokers,
but this finding was not statistically significant (RR = 1.5; 95% Cl: 0.9-2.6) and the highest risks were observed in the
strata of lighter smokers and those with shorter duration of smoking. Overall these results fail to support a negative
association between smoking habits and benign breast disease.
Benign breast disease (BBD) is a heterogeneous group
of changes in the female breast that are strongly
related to ovarian hormones.' For example, BBD is
more frequent in nulliparous women,'"5 and tends to
disappear after the menopause.5"7 Its severity
generally increases in the pre-menstrual period.8
Further, oral contraceptive use has been associated
with a short-term decrease in the risk of BBD, particu-
larly that involving less definite histological
changes.*"'° Oestrogen replacement therapy has been
reported in several, but not all, studies to increase the
risk or exacerbate the symptoms of BBD.""14
Similarly, exogenous oestrogen administration has
been linked with benign mammary lesions in animal
experiments.15"17
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Cigarette smoking has been shown to reduce oestra-
diol levels and availability in women taking oral oestra-
diol,18 and women who smoke have lower urinary
oestrogen levels during the luteal phase of the men-
strual cycle compared to non-smokers.19 More
generally, it is thought that women who smoke cigaret-
tes behave as though they are relatively oestrogen-
deficient. Thus, smoking women show an increased
risk of osteoporosis and early menopause, and a
decreased frequency of endometrial cancer,20-21 and
probably of uterine fibroids22 and pelvic
endometriosis.23
Although these observations suggest that the risk of
BBD might be lower in smokers, the epidemiological
evidence is inconsistent.3'14~ZU4~28 For example, Berko-
witz et al.75 analysing data from a hospital-based case-
control study conducted in the US found that current
smokers, particularly post-menopausal women were at
decreased risk of fibrocystic and benign breast
tumours. The relative risk (RR) for current smokers
was 0.7 for fibrocystic breast disease, 0.6 for fibroade-
noma, and RRs of similar magnitude were registered
for other or combined histological types. A similar
association for fibrocystic disease was reported by
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Wyshak et al. in a cross-sectional surveillance of more
than 5000 former college alumnae,27 but the associ-
ation was not significant for former smokers. No
association emerged in at least three case-control and
cohort studies conducted in the UK,26 Australia28 and
the US3 in which the diagnosis of BBD was self-
reported2* or histologically confirmed.3'28
The contrasting results have been attributed to dif-
fering study design (cohort versus case-control, popu-
lation-based versus hospital-based), although it is
difficult to explain all the apparent contradictions on
this basis alone. Other possible reasons for the appar-
ent discrepancies could be due to the age distribution
of cases studied, since any effect of smoking could be
more evident in post-menopausal women.l4-21-25
In this paper we report the results of a case-control
study conducted in Italy in the early 1980s on the
relation between smoking habits and histologically-
confirmed BBD. Specific attention was paid to col-
lecting detailed information on the histopathological
classification of cases.
SUBJECTS AND METHODS
Between November 1981 and March 1983 we con-
ducted a hospital-based case-control study of BBD.
The design of the investigation has already been
described.5 Briefly, trained interviewers identified and
questioned cases and controls using a structured ques-
tionnaire including information on sociodemographic
factors and personal characteristics and habits, gynae-
cological and obstetric data, related medical history
and use of selected medication. Questions on smoking
included smoking status (ever-smokers being defined
as subjects who had smoked at least one cigarette per
day for at least one year; exsmokers those who had
stopped at least one year previously). The smokers and
exsmokers were asked the total duration (in years) of
the habit and the average number of cigarettes smoked
per day.
Cases were women with histologically confirmed
BBD admitted for the first time to the Division of
Medical Oncology of the Milan Cancer Institute to
undergo breast biopsy. A total of 288 women aged
17-64 years (median age 41) met these criteria. Among
them, 85 (30%) had benign tumours (77 fibroade-
nomas and 8 papillomas) and 203 (70%) had dysplastic
lesions (21 ductal hyperplasias, 49 other dysplasias
such as fibrosclerosis or adenosis, and 133 mixed
lesions). Only clinically important breast lumps, often
suspected of malignancy, are referred for biopsy at the
National Cancer Institute in Milan. It represents a
'second level' referral centre from a network of out-
patient clinics covering the Great Milan area, for sur-
veillance and diagnosis of breast diseases.
Eligible controls were women seen on selected days
for a cytological smear for cervical cancer in outpatient
clinics of the National Cancer Institute of Milan. These
women should constitute a representative sample of
the population in the area attending routine cervical
screening centres. A total of 291 women aged 18 to 68
(median age 40) were identified. None of the eligible
cases or controls refused to be interviewed. Although
cases and controls were not strictly matched, their age
distribution was comparable (Table 1).
Data Analysis
We estimated the odds ratios of BBD, as estimators of
(RRs), together with their 95% confidence intervals
(CI), according to smoking habits, from data stratified
for quinquennia of age by the Mantel-Haenszel pro-
cedure.29 In order to allow for the effects of several
potential confounding factors simultaneously, uncon-
ditional multiple logistic regression, with maximum
likelihood fitting,30 was used. Included in the regres-
sion equations were terms for age, education, meno-
pausal status, Quetelet's index, parity, age at
menarche, oral contraceptive use and, in turn, various
indicators of smoking habits.
RESULTS
The distribution of cases and controls according to his-
topathological classification, age and selected charac-
teristics is shown in Table 1. As expected, women with
benign tumours were younger than those with dysplas-
ias (42% and 22% respectively were less than 35 years
old). No significant difference emerged in relation to
menopausal status or Quetelet's index.
The smoking habits of cases and controls and the
smoking-associated risks are considered in Table 2 and
Table 3. No consistent association emerged between
TABLE 1 Distribution of 288 cases of benign breast disease and 291
controls according to selected characteristics Milan, Italy, 1981-83
Cases
Benign tumours
No.
Age (years)
«25 13
26-35 23
3<M5 33
46-55 15
*56 1
Menopausal status
Pre ' 78
Post 7
%
15
27
39
18
1
92
8
Quetelet's index (kg/m1)
«20 32
20-22 25
*23 28
38
29
33
Dysplasias
No.
8
37
88
51
19
163
40
64
57
82
%
4
18
43
25
9
80
20
32
28
40
Controls
No.
21
62
130
59
19
249
42
88
80
123
%
7
21
45
20
7
86
14
30
27
42
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various indicators of smoking habits (smoking status,
number of cigarettes smoked per day, or duration of
smoking) and risk of BBD. Compared with never
smokers, the overall RR for all BBD was 0.7 (95% CI:
0.4-1.3) for exsmokers, and 1.1 (95% CI: 0.8-1.6) for
current smokers. Among current smokers the RR was
1.4 for fewer than 10 and 1.0 for 10 or more cigarettes
smoked per day. Likewise, there was no relationship
with duration of smoking, with RRs of 1.1 for <20 and
1.2 for ^20 cigarettes per day. The risk of benign
tumours (chiefly fibroadenoma1) was higher in current
smokers, but this finding was not statistically signifi-
cant (RR = 1.5; 95% CI: 0.9-2.5), and the highest
risks were observed in strata of lighter smokers and
shorter duration of smoking. All the multivariate RRs
were largely comparable to the age-adjusted ones.
The effect of smoking was also calculated by meno-
pausal status. Post-menopausal women were defined
as women whose last menstrual cycles occurred at least
one year before interview. Among pre-menopausal
and post-menopausal women the RR of benign breast
disease for current smokers was respectively 1.2 (95%
CI: 0.8-1.8) and 0.6 (95% CI: 0.2-1.7), and 0.7 (95%
CI: 0.3-1.3) and 0.8 (95% CI: 0.2-3.1) for exsmokers.
The post-menopausal risks were, however, based on
seven current and five exsmoker cases versus 14
current and three exsmoker controls only.
DISCUSSION
The results of this analysis do not show any consistent
association between smoking habits and risk of histo-
logically confirmed breast dysplasia or benign
tumours. The overall absence of an association was
confirmed in separate strata of histopathological diag-
nosis of BBD.
It should be stressed that the subjects included in the
present study are not representative of all cases of clini-
cal BBD. They were chosen because they had path-
TABLE 2 Distribution of 288 cases of benign breast disease and 291
controls according to smoking habits. Milan, Italy, 1981-83
Cases
Benign tumours
No. %
Smoking habits
Never 47 55
E* 5 6
Current (cigarettes/day)
<10 18 21
*10 15 18
Duration of smoking (years)
<20 34 89
>20 4 11
Dysplasias
No.
132
14
21
36
46*
22
%
65
7
10
18
68
32
Controls
No.
182
28
29
52
83*
23
%
63
10
10
19
78
22
The sum does not add to the total due to some missing values.
ologically confirmed benign breast lesions often
suspected of being malignant and were referred for
biopsy to the Cancer Institute in Milan. Selection is
probably the major source of potential bias in studies
of BBD and of benign conditions in general.5 For
example, benign breast lumps may be more frequently
detected in women more conscious of health issues
(including for example the health consequences of
smoking). In this regard women referred for cervical
screening seemed an appropriate choice as controls
because of their likely comparable attitudes to health.
Further, this control group, although identified and
interviewed in hospital, does not share the limitation of
hospital controls, particularly the potential over-rep-
resentation of smokers.20 Further, these women were
not specifically referred for cervical abnormalities or
genital infections, and should therefore be a repre-
sentative sample of women attending a routine screen-
ing procedure. Among the determinants of cervical
screening in this population are higher education and
social class (which, if anything, tend to be higher in
BBD cases too), but not smoking.31
It is unlikely that case-control status influenced the
reporting of smoking habits, since at the time of data
collection the potential association between smoking
and BBD had not received widespread attention in
Italy. With regard to confounding, allowing for major
potential distorting factors (including socioeconomic
status or potential risk factors for BBD) did not appre-
ciably change the estimated RR.
Clinical and experimental observations have sug-
gested that oestrogens may play a role in the develop-
ment of BBD. However, available epidemiological
evidence regarding a possible association with smoking
appears inconsistent (see Table 4 for a review). Among
seven studies considered3'1*'24"28 an inverse association
was found between smoking habits and fibrocystic
disease in two case-control14'23 and one cross-sectional
study.27 Fibroadenoma was inversely associated with
smoking status in a case-control study23 and a weak
inverse association was observed in the Walnut Creek
cohort investigation.24 Other studies, however found
risks of BBD in smokers around unity.2628 A direct
relationship between smoking and cystic disease (but
not fibroadenoma) was reported in a population-based
case-control study from Washington county,3 perhaps
reflecting incomplete adjustment for socioeconomic
correlates.
These apparent discrepancies are only partly
explained in terms of potential bias, different study
designs or diagnostic criteria. For example no associ-
ation with smoking was observed in studies considering
either clinical26 or histologically confirmed28 diagnosis
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TABLE 3 Relative risk (and 95% confidence interval) of benign breast disease according to hislopathological classification and selected indicators of
smoking habits. Milan, Italy, 1981-83
Smoking habits
Never
Ex
Current (all)
Benign tumours
MHt
r0.7
(0.3-1.9)
1.5
(0.9-2.5)
Current (no. of cigarettes/day)
<10
s>10
2.3
(1.1-4.4)
1.0
(0.5-2.0)
Duration of smoking (years)
<20
*20
1.6
(0.9-2.8)
0.9
(0.3-3.0)
MLV*
I *
0.6
(0 2-1.8)
1.5
(0 9-2.6)
2.3
(1.1-4.8)
1.0
(0.5-2.1)
1.6
(0.9-3.0)
1.1
(0.3-3.5)
MHt
• +
0.7
(0.4-1.4)
1.0
(0.7-1.5)
1.0
(0.6-1.6)
1.0
(0.6-1.6)
0.9
(0.5-1.4)
1.3
(0.7-2.6)
Dysplasias
MLVJ
1*
0.7
(0.3-1.4)
1.1
(0.7-1.6)
1 1
(0.6-2.1)
1 0
(0 6-1.7)
0.9
(0.6-1.6)
1 4
(0.7-2.8)
MHt
1*
0.7
(0 4-1.3)
1.1
(0.8-1.6)
1.4
(0.8-2.3)
1.0
(0.6-1.6)
1.1
(0.7-1.6)
1.2
(0.6-2.4)
Total
MLVt
1*
0.7
(0.4-1.3)
1.2
(0.8-1.8)
1.4
(0.8-2.5)
1.1
(0.7-1.7)
1.2
(0.8-1.8)
1.3
(0.7-2.6)
tMantel Haenszel estimates adjusted for age only.
^Estimates from multiple logistic regression equations including terms for age, education, menopausal status, Quetelet's index, parity, age at
menarche, oral contraceptive use and, in turn, the above variables.
'Reference category.
of breast disease. In most studies, however, the case
series consisted of women seen for biopsy or surgery of
a breast lump and a potential protective effect could be
stronger on less definite (functional) lesions, as sug-
gested for oral contraceptives.10 Similarly scanty data
are available on post-menopausal women, where the
anti-oestrogenic effect of smoking could be more rele-
vant.21 Two American case-control studies showing a
TABLE 4 Main results from selected epidemiological studies on the relationship between smoking habits and risk of benign breast disease
Authors, country,
year
Study design (number of
considered patients) Main results
Nomura el al, US
19773
Walnut Creek
study, US 1981"
Berkowitz el al.,
US 1985°
Mant et al., UK
1986"
Pastides, US 1987"
Wyshak el al., US
198827
Rohan el al.,
Australia 1989*
Case (n = 320)—control (n - 320) study.
Histologically confirmed diagnosis.
Cohort study.
Hospital discharge diagnoses
Case (n = 959)—control (n - 1062) study.
Histologically confirmed diagnosis.
Cohort study (Oxford-Family Planning
Association Contraceptive study). Mainly
pre-menopausal women.
Case (n - 255)—control (n - 787) study.
Post-menopausal women only.
Histologically confirmed diagnosis.
Cross-sectional analysis of 5398 college
alumnae (aged 21-80 years).
Diagnosis self-reported.
Case (n = 383)—control study; two control
groups: community controls (n — 383) and
biopsy controls (n = 192).
Histologically confirmed diagnoses.
RR* ever versus never smokers = 1.8 for cystic
disease and 0.8 for fibroadenoma.
Heavy smokers appeared to be at slightly
decreased risk of fibroadenoma.
RR (adjusted for age and Queletet's index)
current smokers versus never = 0.6 (95% Cl:
0.5-0.8) for fibrocystic disease, 0.7 (95% CI:
0.5-0.9) for fibroadenoma and 0.6 (95% Cl: 0.3-
1.0) for mixed lesion. No association in
exsmokers. Stronger association in post-
menopause.
The first hospital visit rates for BBD were 5.7,
5.9 and 6.4/1000 woman-years respectively in
never smokers and in current smokers of 1, 14
and 15 or more cigarettes/day.
RR (age-adjusted) ever versus never
smokers = 0.5 (95% CI: 0.2-0.8) for fibrocystic
disease.
RR of current versus never smokers = 0.5 (95%
CI: 0.3-0.8) for breast biopsy or fibrocystic
disease.
RR current smokers versus never = 0.9 (95%
CI: 0.7-1.3) versus community controls and 1.1
(95% CI: 0.7-1.6) versus biopsy controls. No
association both in pre- and post-menopause.
*RR = relative risk; CI = confidence interval.
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protective effect of smoking on BBD found a stronger
relationship in post-menopausal women,"'25 but an
Australian study of proliferative lesions did not
observe any relationship in either pre- or post-meno-
pausal women.2* In our series the risk of BBD was
about 40% lower in post-menopausal current smokers;
this finding was based on seven current smokers cases
only and was not statistically significant. The present
study, therefore, provides only limited information on
the relationship between smoking and BBD after
menopause.
In conclusion, despite a plausible biological
rationale,21 and some suggestive previous findings, the
present data (as well as several other studies) fail to
support the presence of a consistent negative associ-
ation between smoking and BBD.
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